Sign Up Today and Learn More About Sibel Health Stock
Invest in or calculate the value of your shares in Sibel Health or other pre-IPO companies through EquityZen's platform.
Sibel Health Stock (SIBH)
Sibel Health develops a neonatal epidermal system designed for wireless vital signs monitoring.
About Sibel Health Stock
Founded
2018
Headquarters
Niles, IL, US
Industries
Software, Artificial Intelligence, Data and Analytics
Sibel Health Press Mentions
Stay in the know about the latest news on Sibel Health
Sibel Health and LookDeep Health Announce Strategic Partnership to Combine Continuous Vitals with Real-Time Bedside AI - Without Lock-In
prnewswire • Feb 25, 2026
FDA accepts Sibel Health’s Aria sensor for COA qualification
medicaldevice-network • Feb 21, 2026
Sibel Health Receives FDA Acceptance into Drug Development Tool Qualification Program for Innovative Cough Monitoring Sensor
biospace • Feb 20, 2026
Sibel Health Receives FDA Acceptance into Drug Development Tool Qualification Program for Innovative Cough Monitoring Sensor
prnewswire • Feb 19, 2026
Sibel Health Awarded a $500,000 Drug Development Tools Research Grant by the FDA for a Novel AI-Enabled Wearable Sensor for Scratch Monitoring
prnewswire • Dec 09, 2025
Sibel Health Management
Leadership team at Sibel Health
Board Member
John Rogers
CEO
Shuai Xu
Join now and verify your accreditation status to gain access to:
- Sibel Health Current Valuation
- Sibel Health Stock Price
- Sibel Health Management
- Available deals in Sibel Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Sibel Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Sibel Health Revenue and Financials
- Sibel Health Highlights
- Sibel Health Business Model
- Sibel Health Risk Factors
- Sibel Health Research Report from SACRA Research
Trading Sibel Health Stock
How to invest in Sibel Health stock?
Accredited investors can buy pre-IPO stock in companies like Sibel Health through EquityZen funds. These investments are made available by existing Sibel Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Sibel Health stock?
Shareholders can sell their Sibel Health stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
